Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Tecfidera

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tecfidera was produced by Biogen Idec.

EMA clears BMS’ oral multiple sclerosis drug Zeposia

EMA clears BMS’ oral multiple sclerosis drug Zeposia

There are other entrenched oral therapies to contend with, notably Biogen’s Tecfidera (dimethyl fumarate) which also has low-cost generics on the horizon that could exert downward pressure on oral

J&J aims for US approval of MS drug ponesimod

J&J aims for US approval of MS drug ponesimod A range of blockbuster therapies are already available for MS, including Biogen’s Tecfidera (dimethyl glutamate) and new injectables like Roche’s Ocrevus (ocrelizumab). ... There is also the looming threat of generic competition to Gilenya and

Biogen triumphs over Mylan’s Tecfidera patent challenge

Biogen triumphs over Mylan’s Tecfidera patent challenge The challenge from Mylan focused on Biogen’s ‘514 patent on Tecfidera (dimethyl fumarate) , which is due to expire in 2028. ... Circuit to remove this patent from blocking generic competition to Tecfidera," they added.

Biogen under fire over $88,000 Vumerity annual price

Biogen under fire over $88,000 Vumerity annual price Vumerity is Biogen’s answer to the patent pressures on Tecfidera, but there have been concerns that. ... patients who are stable on Tecfidera will be unwilling to to transfer to the newer drug.

Biogen’s R&D chief Ehlers heads for the exit

Biogen’s R&D chief Ehlers heads for the exit There are more immediate problems at Biogen however. Multiple sclerosis blockbuster Tecfidera (dimethyl glutamate) is coming under increasing competitive pressure, and analysts aren’t confident that a follow-up with an ... improved tolerability profile

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics